Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

´ëÀå¾Ï¿¡¼­ÀÇ nm23°ú CD44 ´Ü¹éÁú ¹ßÇö¿¡ ´ëÇÑ ¸é¿ªÁ¶Á÷ÇÐÀû ºÐ¼® Immunohistochemieal Study of Expression of nm23 and CD44 Protein in Colorectal cancer

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 1997³â 13±Ç 1È£ p.15 ~ 21
½Åµ¿ÀÏ, À̱âÇü, À±Ãæ, ÀÌÁÖÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
½Åµ¿ÀÏ ( Shin Dong-Il ) 
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

À̱âÇü ( Lee Kee-Hyung ) 
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
À±Ãæ ( Yoon Choong ) 
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÀÌÁÖÈñ ( Lee Joo-Hee ) 
°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Gene expression of the nm23 and CD44 has been investigated in number of tumors, in cluding colorectal cancer, breast cancer, and hepatocellular carcinoma. This study was conducted to clarify the association between nm23 and CD44 protein expression and metastatic potential in human colorectal cancer. To elucidate the role of the nm23 and
CD44 in human colorectal cancer, sections of formalin-fixed, paraffin-embeded tissue from 59 primary colorectal cancer were stained immunohistochemically against nm23 and CD44 proteins. Expression of the nm23 protein is not significantly correlate with Dukes¡¯stage and recurrence. However, the expression of the CD44 protein is significantly higher in Dukes stage C as comparing with stage B.

Å°¿öµå

Colorectal Neoplasms;nm23 H1 Protein;Recurrence

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS